RP is primarily a genetic condition passed from parents to children through DNA. Understanding the inheritance pattern helps families assess their own risk and make informed decisions about testing and family planning.
RP follows several distinct inheritance patterns, each carrying a different level of risk for family members.
Knowing which pattern applies in a family is important for genetic counseling and for understanding the risk to siblings and children.
Some people with RP also have conditions that affect other parts of the body. Usher syndrome, the most common syndromic form, causes both vision loss from RP and hearing loss. Bardet-Biedl syndrome can involve RP alongside obesity, kidney problems, and other features. Genetic testing can clarify whether RP is occurring on its own or as part of a broader condition.
RP typically develops slowly, and early symptoms can be subtle enough that patients do not immediately recognize them as a vision problem. Knowing what to look for helps ensure that evaluation happens before significant vision is lost.
Difficulty seeing in dim light or darkness, called night blindness or nyctalopia, is usually the first symptom of RP. It often begins in childhood or adolescence. Someone with early RP may struggle to navigate a dark room, have trouble driving at dusk, or find it hard to adjust when moving from a bright space into a poorly lit one.
As rod cells continue to break down, peripheral vision narrows progressively. People may begin bumping into objects at the edges of their visual field or fail to notice things that are not directly in front of them. Over time, this narrowing can create what is often described as tunnel vision, where only a small central area of sight remains.
When cone cells are also affected, central vision begins to decline. This can make reading, recognizing faces, and distinguishing colors more difficult. The timeline for central vision loss varies considerably. Some individuals retain useful central vision well into adulthood, while others experience decline earlier.
Children often do not recognize or report vision problems on their own. Parents should watch for a child frequently tripping or bumping into furniture in low-light conditions, reluctance to go outside after dark, or difficulty keeping up with peers in dimly lit spaces. If any of these behaviors appear, especially with a family history of RP, an evaluation by a retina specialist is important.
Diagnosing RP involves a combination of clinical examination, specialized retinal testing, and in many cases genetic analysis. Early and accurate diagnosis gives patients the best opportunity to access monitoring, counseling, and emerging treatments.
A retina specialist typically begins with a dilated eye exam, using drops to widen the pupil so the retina can be examined directly. The characteristic pigment deposits, thinned vessels, and pale optic disc associated with RP are often visible at this stage. Electroretinography (ERG) is a key follow-up test that measures the electrical response of the retina to light. In RP, the signals from rod and cone cells are weaker than normal or absent entirely. Importantly, ERG can detect RP before symptoms are noticeable, making it a valuable tool for screening at-risk family members.
Visual field testing maps which areas of vision are still functioning, helping the specialist track how much peripheral vision remains and whether it is changing over time. Optical coherence tomography (OCT), a non-invasive retinal imaging scan, provides detailed cross-sectional images of the retinal layers. OCT can reveal thinning and structural changes that confirm RP and help track disease progression. Additional imaging tools used in our retina clinic include fluorescein and ICG angiography, color fundus photography, and B-scan echography.
A blood or saliva sample can be analyzed to identify the specific gene mutation causing RP. Knowing the exact mutation confirms the diagnosis, clarifies the inheritance pattern, supports family planning decisions, and determines whether a patient may be eligible for gene therapy or enrollment in clinical trials. Genetic testing has become a standard and increasingly important part of RP care.
There is currently no treatment that can fully reverse the vision loss caused by RP. However, several approaches can help slow progression in select patients, manage complications, and preserve quality of life. Our retina specialists stay current with emerging therapies and can guide patients through their options.
Luxturna (voretigene neparvovec) is the first FDA-approved gene therapy for an inherited retinal disease. It is designed for patients with RP or Leber congenital amaurosis caused by mutations in both copies of the RPE65 gene, which accounts for a small percentage of all RP cases. The therapy delivers a functioning copy of the RPE65 gene directly into the retina through a surgical procedure, and clinical studies have shown meaningful improvements in the ability to navigate in low-light conditions. Genetic testing is required to confirm eligibility, as Luxturna is not applicable to all forms of RP.
Some research has suggested that vitamin A palmitate may slow retinal degeneration in certain RP patients. However, high doses of vitamin A can be harmful, particularly to the liver, and are not safe for everyone. This supplement should never be started without guidance from a retina specialist or physician, and it is not recommended for pregnant women or those planning pregnancy.
People with RP are more likely to develop certain other eye conditions that can further reduce vision. Cataracts (clouding of the eye's natural lens) are common and can often be treated with surgery. Cystoid macular edema (swelling in the central retina) can also occur and may be managed with medications such as carbonic anhydrase inhibitors. Identifying and treating these complications early can help preserve functional vision.
Low vision rehabilitation helps people with RP make the most of their remaining sight. Tools such as magnifying devices, telescopic lenses, high-contrast screens, and text-to-speech software can assist with daily activities. Orientation and mobility training helps individuals move safely through their environment. A retina specialist can provide referrals to low vision services tailored to each patient's level of vision.
Adapting to a progressive vision condition takes time, support, and practical planning. There are meaningful steps patients can take to protect their remaining vision, stay informed about research, and prepare for the future with confidence.
While no intervention has been proven to stop RP entirely, certain habits may help reduce additional stress on the retina. Wearing UV-protective sunglasses outdoors is commonly recommended, as is avoiding smoking, which has been linked to worse outcomes in many retinal conditions. Maintaining general health through regular physical activity and a balanced diet also supports overall eye health.
Research into RP treatments is advancing on several fronts. Optogenetic therapy, which aims to make surviving retinal cells responsive to light even after photoreceptors are lost, has shown early promise in clinical trials. Gene therapies targeting mutations such as RPGR in X-linked RP are in advanced stages of testing. CRISPR-based gene editing has corrected rhodopsin mutations in laboratory models, raising hope for future applications. These therapies are not yet available outside of clinical trials. A retina specialist can help determine whether a patient may qualify for a trial and provide guidance as options develop.
Genetic counseling is recommended for individuals diagnosed with RP and their family members. A genetic counselor can explain what test results mean, help relatives understand their own risk, and clarify the likelihood of passing the condition to future children. For families who are planning to have children, this guidance can be especially valuable in making informed decisions.
Knowing when to contact a retina specialist, and when to seek urgent care, is an important part of managing RP. Prompt action at the right time can protect vision and prevent additional complications.
Although RP itself progresses slowly, certain symptoms require immediate evaluation. A sudden increase in floaters, new flashes of light, a shadow or curtain moving across the vision, or any abrupt loss of vision should be treated as a medical emergency. These symptoms may indicate a retinal detachment or other serious condition requiring rapid treatment. Please seek care from a retina specialist or emergency room right away if any of these occur.
Even when vision feels stable, regular visits with a retina specialist are essential. Ongoing monitoring with ERG, visual field testing, and OCT imaging allows the specialist to track retinal health and detect changes early. These visits also ensure that complications like cataracts or macular edema are identified when treatment is most effective. If RP is suspected based on symptoms or family history, an evaluation is the right first step, and genetic testing can be arranged at that visit.
These answers address common questions patients and families have after learning about RP, with a focus on practical decisions and next steps.
Yes, and early detection can be meaningful. Electroretinography can reveal reduced retinal electrical activity before noticeable vision changes occur. Genetic testing can identify a mutation in at-risk relatives who have no symptoms at all. If a parent, sibling, or child has been diagnosed with RP, asking a retina specialist about baseline testing is worthwhile even if your vision currently feels normal. Having that information on record allows for timely comparison if changes develop.
Not at this time. Luxturna is the only FDA-approved gene therapy for inherited retinal disease, and it applies only to patients with RPE65 gene mutations, which represent a small subset of all RP cases. Other gene therapies targeting different mutations are currently in clinical trials but have not yet received regulatory approval. Genetic testing is the essential first step to know whether any existing or upcoming therapy is applicable to your specific mutation.
The answer depends on the specific mutation and inheritance pattern involved. In autosomal dominant RP, each child of an affected parent has roughly a one in two chance of inheriting the condition. In autosomal recessive RP, both parents must carry the mutation for a child to be affected, giving each child approximately a one in four chance. In X-linked RP, carrier mothers have roughly a one in two chance of passing the mutation to sons, who would then be affected. A genetic counselor can provide personalized risk information based on your family's specific test results.
No lifestyle change has been proven to stop RP, but several habits are generally recommended to support retinal health. Wearing UV-blocking sunglasses, avoiding smoking, and eating a diet rich in leafy greens and omega-3 fatty acids are commonly suggested. Some retina specialists may discuss vitamin A supplementation for certain patients, but this must only be considered under direct medical supervision given the potential for serious side effects at high doses.
Schedule a comprehensive eye examination with a retina specialist that includes electroretinography. Even without symptoms, an ERG provides a baseline measurement of retinal function that can be compared to future results. Genetic testing can confirm whether you carry a mutation associated with RP. If you are planning a family, a genetic counselor can help you understand the implications for your children before testing decisions are made.
The appropriate frequency depends on how quickly your condition is progressing and whether complications are present. Most patients with RP benefit from monitoring at least once a year, while those with faster progression or active complications may need more frequent visits. Each visit is an opportunity to update imaging, track visual field changes, review any new treatment options, and address questions. Your retina specialist will recommend a monitoring schedule based on your individual situation.
Our visiting retina specialists bring fellowship-trained expertise in inherited retinal disease, vitreoretinal surgery, and medical retina care to patients across Northern Virginia through our dedicated retina clinic. Whether you are newly diagnosed with RP, managing a long-standing condition, or simply concerned about a family history, we are here to provide thorough evaluation, honest guidance, and compassionate ongoing care. We invite you to schedule an appointment with our team and take an important step toward understanding and protecting your vision.
